logo
Share SHARE
FONT-SIZE Plus   Neg

Arrow Financial Q1 Profit Edges Up - Quick Facts

Arrow Financial Corp. (AROW), Wednesday, reported a slight increase in profit for the first quarter.

The Glens Falls, New York-based multi-bank holding company reported a first-quarter net profit of $5.29 million, compared to $5.28 million. On a per-share basis, earnings was flat at 45 cents.

Net interest income for the quarter dropped to $14.41 million from $14.55 million, where as net interest income after provision for loan losses decreased to $14.13 million from $14.33 million in the prior-year quarter.

For the quarter, total non-interest income rose to $6.56 million from $5.62 million in the prior-year quarter.

For the quarter, the company paid a cash dividend to its shareholders of $0.25, a 3 percent increase from the prior-year quarter.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Almost 71 percent of Americans say they don't save enough for their retirement, while around 54 percent believe they will never pay off their debt fully, according to a new national survey. The latest survey, commissioned by Experian together with Get Rich Slowly and other top U.S. personal finance... The biotech space is not for the faint hearted, given the ebbs and flows in terms of the returns from investing in it. However, for one who perseveres and astutely devises strategies with full cognizance of key regulatory events coming up, the probability of drug candidates getting FDA's blessings and sympathy plays in the space, it provides a sea of opportunity and huge upside prospects. Alcobra Ltd.'s Investigational New Drug Applications for drug candidate MDX in Attention Deficit Hyperactivity Disorder and Fragile X Syndrome have been put on full clinical hold, following adverse neurological findings in a pre-clinical study.
comments powered by Disqus
Follow RTT